Pharmacokinetic and Pharmacodynamic Profile of New Biosimilar Filgrastim XM02 Equivalent to Marketed Filgrastim Neupogen: Single-Blind, Randomized, Crossover Trial
Lubenau, Heinz, Bias, Peter, Maly, Anne-Katrin, Siegler, Karl Ernst, Mehltretter, Kai
Published in BioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy (2009)
Published in BioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy (2009)
Get full text
Journal Article
GlycoPEGylated Filgrastim XM22 Demonstrates Dose-Dependent Activity in Comparison to Pegfilgrastim in a Dose-Escalating Study in Healthy Volunteers after Body-Weight Dependent Single Dose
Lubenau, Heinz, Pokorny, Rolf, Lopez-Lazaro, Luis, Bias, Peter, Wallin, Bruce, Hinderer, Walter, Maly, Anne-Katrin, Seiberling, Michael
Published in Blood (16.11.2007)
Published in Blood (16.11.2007)
Get full text
Journal Article
GlycoPEGylated Filgrastim XM22 Fixed Dose Demonstrates Similar Activity in Comparison to Pegfilgrastim in Healthy Volunteers after Single Administration
Lubenau, Heinz, Pokorny, Rolf, Lopez-Lazaro, Luis, Bias, Peter, Wallin, Bruce, Hinderer, Walter, Maly, Anne-Katrin, Seiberling, Michael
Published in Blood (16.11.2007)
Published in Blood (16.11.2007)
Get full text
Journal Article